Skip to main content- 2023
CDK4/6 inhibitor resistance in estrogen receptor positive breast cancer, a 2023 perspective.
Fiona H Zhou, Teesha Downton, Allegra Freelander, Joshua Hurwitz, C Elizabeth Caldon, Elgene Lim - 2021
Type 1 Nuclear Receptor Activity in Breast Cancer: Translating Preclinical Insights to the Clinic.
Sanjeev Kumar, Allegra Freelander, Elgene Lim - 2021
Molecular Biomarkers for Contemporary Therapies in Hormone Receptor-Positive Breast Cancer.
Allegra Freelander, Lauren J Brown, Andrew Parker, Davendra Segara, Neil Portman, Brandon Lau, Elgene Lim